1. 1Q07 Earnings Release
1

2. Highlights For The Period
– Opening of new Distribution Center in Ceará
– Market of R$ 987.6 millions covering Ceará, Maranhão and Piauí
– Profarma reached 83.5% of national market
– R$ 555.3 million Gross Revenue, up 26.8% in comparison with 1Q06
– Adjusted EBITDA registered 17.8% increase related to 1Q06, reaching
R$15.0 millions on 1Q07
– R$ 5,1 million Net Income on 1T07, 324.1% increase in comparison with
1Q06
– Pernambuco branch, opened on january, reached R$ 6.4 million Gross
Revenue on 1T07
2

3. Gross Revenue Evolution
In R$ MM
26.8%
555.3
528.6
437.9
1Q06 4Q06 1Q07
3

4. Gross Revenue Breakdown
In R$ MM
(R$ Million) 1Q07 1Q06 Variation % 4Q06 Variation %
Branded 374.0 303.1 23.4% 347.8 7.5%
Generics 33.0 22.8 44.9% 36.5 -9.5%
OTC 99.0 74.8 32.4% 96.1 3.1%
Health and Beauty Products 37.4 29.2 27.9% 36.4 2.6%
Others 11.7 7.4 57.7% 11.6 0.6%
Services Rendered 0.2 0.6 -59.7% 0.3 -19.3%
Total 555.3 437.9 26.8% 528.6 5.1%
4

5. Market Share (%)
10.7
9.3 9.6 9.6
8.4
2003 2004 2005 2006 1Q07
Source: IMS
5

6. Gross Profit
In R$ MM and as % Net Revenues
8.9% 8.9%
8.3%
41.1 42.8
31.9
1Q06 4Q06 1Q07
6

7. Operating Expenses
% Net Revenue
8.1%
7.8% 7.7%
1Q06 4Q06 1Q07
EXPENSES: General and Administrative + Selling and Marketing + Logistics and Distribution
7

8. Net Financial Expenses
% Net Revenue
2.0%
1.0%
0.6%
1Q06 4Q06 1Q07
8

9. Net Income
In R$ MM and as % Net Revenues
2.8%
1.1%
0.3% 12.7
5.1
1.2
(12.5)
1Q06 4Q06 1Q07
Net Income
Adjusted Net Income
9

10. Adjusted EBITDA and
EBITDA Margin
In R$ MM and as % Net Revenues
4.2%
3.3% 3.1%
19.4
15.0
12.7
1Q06 4Q06 1Q07
4Q06 – Adjusted by IPO expenses
10

11. Cash Flow
CASH FLOW
(R$ Million) 1Q07 1Q06 % Variation 4Q06 % Variation
Cash Flow Used in Operating Activities (58.0) (4.4) -1218.6% (14.8) -292.0%
Internal Cash Generation 10.5 5.2 100.0% 18.5 -43.4%
Operating Assets Variation (68.5) (9.6) -610.5% (33.3) -105.7%
Duplicate Trade Bills Receivable (43.4) 4.2 -1140.5% (27.8) -56.0%
Inventories (3.4) (0.6) -482.5% (53.5) 93.6%
Suppliers (19.1) (13.9) -38.2% 56.7 -133.7%
Other Items (2.5) 0.6 -497.9% (8.7) 71.2%
Cash Flow Used in Investing Activities (0.9) 0.3 -444.6% (2.2) 57.8%
Cash Flow Generated by Financing Activities 0.5 9.2 -94.6% 201.6 -99.8%
Net Increase (Decrease) in Cash (58.4) 5.1 -1244.3% 184.6 -131.7%
11

12. Indebtedness
In R$ MM
Net Debt (R$MM) and Net Debt / Ebitda
112.2
1.7
-0.1
-4.1
-1.0
-64.7
1Q06 4Q06 1Q07
4Q06 – Adjusted by IPO expenses
* Ebitda = Ended 12 months
12

13. Capex
In R$ MM and as % Net Revenues
0.5%
0.2%
0.1%
2.3
0.9
0.3
1Q06 4Q06 1Q07
13

14. Operating Indicators
Service Level
(units served / units requested)
91.2%
90.0%
86.4%
89.9%
1Q06 4Q06 1Q07
Without Pernambuco
14

15. Operating Indicators
Logistics E.P.M. Logistics – Productivity
(Errors per Million) (units shipped / worked hours)
202.0 84.8
97.7
209.0
88.2
200.0 201.0 82.4
1Q06 4Q06 1Q07 1Q06 4Q06 1Q07
Without Pernambuco Without Pernambuco
15

16. Operating Indicators
Sale per Square Meter Average Sale per DC
13.4 68.6
12.9
10.7
13.2
66.1 61.7
54.7
1Q06 4Q06 1Q07 1Q06 4Q06 1Q07
Without Pernambuco Without Pernambuco
.In R$ thousands (Gross Revenue) .In R$ MM (Gross Revenue)
16

17. Operating Indicators
Average invoice Sale Through Eletronic Orders
850
45.8%
845 848
45.7%
44.2%
780 43.1%
1Q06 4Q06 1Q07 1Q06 4Q06 1Q07
Without Pernambuco Without Pernambuco
. R$ % on total sale
17

18. Operating Indicators
Gross Revenue per Employee Ebitda per Employee
14.43
10.22
9.04
393.3
351.4 334.5
1Q06 4Q06 1Q07 1Q06 4Q06 1Q07
. In R$ thousands . In R$ thousands
18

19. Capital Markets
* 100 pts basis on 25/oct/2006
179
175
171
167
163
159
155
149
151
147
143
139
135
131
127
123
119 117
115
115
111
107
103
99
95
ar
ar
ar
ar
ez
ez
ez
z
n
n
n
ov
ov
v
v
ut
ev
ev
de
fe
no
ja
ja
ja
-m
-m
-m
m
-d
-d
-d
-o
-n
-n
-f
-f
-
-
9-
5-
1-
3-
5-
17
26
25
11
19
28
13
23
13
23
13
22
30
Ibovespa IGC Profarma
19

20. RI Contact:
Max Fischer
CFO and IRO
Ana Paula Ribeiro
IR Coordinator
phone.: 55 (21) 4009 0276
E-mail: ri@profarma.com.br
www.profarma.com.br/ri
20